Small steps to address exchange obstacles

Even as surveys continue to point out the ongoing challenges to health information exchange (HIE), other developments are helping to address those barriers in small steps.

For example, the Workgroup for Electronic Data Interchange (WEDI) will extend free membership for all federal and state government agencies and their corresponding departments as part of its efforts to spur HIE improvements.

All federal and state government agencies and departments will be provided access to WEDI's resources including whitepapers, issue briefs, webinars, networking opportunities, industry best practices and updates on regulatory, legislative and standards changes. Membership also offers the opportunities to influence the direction of health IT policy through WEDI’s Policy Advisory Groups, officials said.

However, a survey of physicians conducted by Doctors Helping Doctors Transform Health Care, found several obstacles keeping them from participating in exchange. Those obstacles includes lack of interoperability between various EHR systems (cited as a major barrier by 71 percent of respondents); lack of infrastructure to support an HIE (71 percent); and the costs of setting up and maintaining interfaces and exchanges (68 percent).

Minor barriers cited included privacy and security concerns, worries about malpractice liability if information isn’t acted on, and concerns about not being able to trust data in the exchange.

How are you and your organization progressing with information exchange? Please share your experience.

Beth Walsh

Editor, Clinical Innovation + Technology

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.